Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project
Article first published online: 7 MAR 2013
© 2013 John Wiley & Sons Ltd
Tropical Medicine & International Health
Volume 18, Issue 6, pages 725–733, June 2013
How to Cite
Ostyn, B., Malaviya, P., Hasker, E., Uranw, S., Singh, R. P., Rijal, S., Sundar, S., Dujardin, J.-C. and Boelaert, M. (2013), Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project. Tropical Medicine & International Health, 18: 725–733. doi: 10.1111/tmi.12092
- Issue published online: 20 MAY 2013
- Article first published online: 7 MAR 2013
- WHO Leishmaniasis Control Team 2012 Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7, e35671. doi: 10.1371/journal.pone.0035671. Epub 2012 May 31. , , et al.;
- 2006) Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible and operationally achievable. Indian Journal of Medical Research 123, 195–196. , , & (
- 2009) The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Tropical Medicine and International Health 14, 639–644. , , et al. (
- 2001) Epidemiological analysis of tuberculosis treatment outcome as a tool for changing TB control policy in Israel. The Israel Medical Association Journal 3, 479–483. , , & (
- 2006) Drug resistance in leishmaniasis. Clinical Microbiology Reviews 19, 111–126. , & (
- 2010) Management of visceral leishmaniasis in rural primary health care services in Bihar, India. Tropical Medicine and International Health 15, 55–62. , , et al. (
- 2006) Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities. Kathmandu University Medical Journal 4, 488–496. , , , , & (
- 2012a) Cohort monitoring of persons with diabetes mellitus in a primary healthcare clinic for Palestine refugees in Jordan. Tropical Medicine and International Health 17, 1569–1576. , , et al. (
- 2012b) Cohort monitoring of persons with hypertension: an illustrated example from a primary healthcare clinic for Palestine refugees in Jordan. Tropical Medicine and International Health 17, 1163–1170. , , et al. (
- 2007) Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi. Tropical Medicine and International Health 12, 377–381. , , et al. (
- 2012 The power of health information– the use of cohort monitoring in managing patients with chronic non-communicable diseases. Tropical Medicine and International Health 17, 1567–1568.
- 2011) Monitoring drug effectiveness in kala-azar in Bihar, India: cost and feasibility of periodic random surveys versus a health service-based reporting system. Tropical Medicine and International Health 16, 1159–1166. , , et al. (
- 2013) Village health workers in Bihar, India: an untapped resource in the struggle against kala-azar. Tropical Medicine and International Health 18, 188–193. , , , , & (
- 2009) Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Neglected Tropical Diseases 3, e355. doi:10.1371/journal.pntd.0000355. , , , et al. (
- 2002) Tuberculosis treatment outcome monitoring: Blackburn 1996–2000. Journal of Infection 45, 88–89. , & (
- 2013) Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, re-infection or non-compliance. Clinical Infectious Diseases [Epub ahead of print]. , , et al. (
- 2011) Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Neglected Tropical Diseases 5, e960. doi:10.1371/journal.pntd.0000960. , , et al. (
- 2002) Oral miltefosine for Indian visceral leishmaniasis. New England Journal of Medicine 347, 1739–1746. , , et al. (
- 2012) Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clinical Infectious Diseases 55, 543–550. , , et al. (
- TDR/World Health Organization 2010 Indicators for monitoring and evaluation of the kala-azar elimination programme. World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases.
- UNRWA Health Department (2009) Technical Instructions and Management Protocols on Prevention and Control of Non-Communicable Diseases. Technical Instruction Series: Number HD⁄DC⁄ 01 ⁄ 1997. Revision No.4 – June 2009
- 1998) Standardized tuberculosis treatment outcome monitoring in Europe. European Respiratory Journal 12, 505–510. , , et al. (
- 2007) WITHDRAWN: interventions for promoting adherence to tuberculosis management. Cochrane Database Systematic Review 18, CD000010. & (
- World Health Organization; International Union Against Tuberculosis and Lung Disease; Royal Netherlands Tuberculosis Association 2001 Revised international definitions in tuberculosis control. The International Journal of Tuberculosis and Lung Disease 5, 213–215.
- World Health Organization 2003 Global Tuberculosis Control. Surveillance, Planning, Financing. WHO Report 2003. Document WHO/CDS/TB/2003.316. World Health Organization, Geneva.
- World Health Organization (2005) Regional office for South-East Asia. Regional Strategic Framework for Elimination of Kala-azar from the South-East Asia Region (2005-2015)[document on the internet]. WHO SEARO, New Delhi. Available from: http://www.searo.who.int/LinkFiles/Kala_azar_VBC-85_Rev_1.pdf. (accessed 29 June 2012).
- World Health Organization 2006 Revised TB recording and reporting forms and registers – version 2006 WHO/HTM/TB/2006.373 available on http//whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.373_eng.pdf (accessed 1 December 2012).